Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

CPSE:NOVO B
CPSE:NOVO BPharmaceuticals

How Investors May Respond To Novo Nordisk (CPSE:NOVO B) Pursuing Oral GLP-1 Use In Teen Diabetes

Earlier this month, Novo Nordisk reported positive Phase 3a PIONEER TEENS results showing its oral semaglutide cut HbA1c significantly versus placebo in 10–17-year-olds with type 2 diabetes, and said it plans to seek US and EU label expansions in the second half of 2026. By opening the door for the first oral GLP-1 therapy in youth-onset type 2 diabetes, Novo Nordisk is targeting a large, under-treated global patient group where current options like metformin and insulin have important...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Broadcom (AVGO) Is Up 5.8% After New Meta AI Deal And Google Cloud Tie-Up - What's Changed

Broadcom’s recent announcements include an expanded Google Cloud collaboration on the Cloud Network Insights observability service, a new VMware Tanzu Platform agent runtime for autonomous AI applications, and a multi-year, multi-generation AI infrastructure partnership with Meta extending through 2029. Together, these moves deepen Broadcom’s role at the center of hyperscale AI data centers and secure AI operations, potentially reinforcing demand visibility across both its custom AI silicon...
NasdaqGS:AFYA
NasdaqGS:AFYAConsumer Services

Afya (NasdaqGS:AFYA) Valuation Check After Recent Share Price Weakness

How Afya stock has been trading Afya (NasdaqGS:AFYA) has been under pressure recently, with the share price showing a 2.6% decline over the past day and double digit negative returns over the past week, month, past 3 months and year. Year to date, the stock is also in negative territory, while the 3 year total return remains positive. This mix of shorter term weakness and longer term gains sets the backdrop for assessing what the current price might already reflect. At the last close of...
NYSE:BIO
NYSE:BIOLife Sciences

Assessing Bio-Rad Laboratories (BIO) Valuation After Citi Downgrade And China Diagnostics Concerns

Citi downgrade puts Bio-Rad Laboratories (BIO) under closer scrutiny Citigroup’s move to cut Bio-Rad Laboratories (BIO) to Neutral and lower its outlook on the stock has refocused attention on the company’s process chromatography margins and diagnostics exposure to China. See our latest analysis for Bio-Rad Laboratories. Bio-Rad’s 8.46% one-month share price return contrasts with a 5.71% year-to-date share price decline. The one-year total shareholder return of 19.85% also sits against a...
TWSE:3605
TWSE:3605Electronic

Exploring Three High Growth Tech Stocks In Asia

As global markets continue to navigate geopolitical tensions and economic uncertainties, the Asian tech sector remains a focal point for investors seeking high growth opportunities. In this dynamic environment, identifying promising tech stocks involves looking for companies with robust innovation capabilities, strong market positioning, and the ability to capitalize on emerging technologies such as artificial intelligence.
KOSDAQ:A458870
KOSDAQ:A458870Medical Equipment

Asian Value Stocks Trading At Estimated Discounts

In recent weeks, Asian markets have shown relative stability, with China's equities consolidating gains and Japan's stock indices experiencing mixed returns amid ongoing geopolitical tensions in the Middle East. As investors navigate these uncertain times, identifying undervalued stocks can be a strategic approach to potentially capitalize on market inefficiencies, especially when strong fundamentals suggest a stock is trading below its intrinsic value.
SHSE:603538
SHSE:603538Pharmaceuticals

Three Undiscovered Gems In Asia To Enhance Your Portfolio

As global markets navigate geopolitical uncertainties and shifting economic conditions, the Asian market continues to present unique opportunities for investors seeking growth outside traditional Western indices. With a focus on resilience amid volatility, identifying stocks with strong fundamentals and innovative potential can be key to enhancing your portfolio in this dynamic region.
SHSE:600096
SHSE:600096Chemicals

Asian Dividend Stocks To Enhance Your Portfolio

As Asian markets navigate a landscape marked by geopolitical tensions and evolving economic indicators, investors are increasingly turning their attention to stable income-generating opportunities. In this context, dividend stocks in Asia offer a compelling proposition for those seeking to enhance their portfolios with reliable returns amidst market uncertainties.
XTRA:DHER
XTRA:DHERHospitality

Delivery Hero (XTRA:DHER) Valuation Check As Herogen AI Agent Reshapes Engineering Capacity

Delivery Hero (XTRA:DHER) has put artificial intelligence at the center of its tech story with Herogen, an in-house autonomous coding agent that already produces output comparable to 130 senior engineers. See our latest analysis for Delivery Hero. The share price is at €19.50 and the 30 day share price return of 17.33% sits against a year to date share price decline of 14.55% and a 1 year total shareholder return decline of 26.61%. This suggests that recent momentum contrasts with weaker...
NYSE:KNSL
NYSE:KNSLInsurance

Is Kinsale Capital Group (KNSL) Offering A Compelling Entry Point After Recent Share Price Swings

If you are wondering whether Kinsale Capital Group at around US$345 per share looks like value or a value trap, the next sections break down what the current price might be implying. The stock has been volatile recently, with a 4.4% decline over the last 7 days, a 5.4% gain over 30 days, and returns of 12.1% decline year to date and 17.7% decline over the last year, set against 6.1% and 100.1% gains over 3 and 5 years respectively. Recent coverage around Kinsale Capital Group has focused on...
NasdaqGS:ANAB
NasdaqGS:ANABBiotechs

Does AnaptysBio’s (ANAB) Legal Win on Jemperli Royalties Reshape Its Partnership Power Balance?

In April 2026, AnaptysBio announced that the Delaware Chancery Court dismissed Tesaro’s anticipatory breach of contract claim, rejecting Tesaro’s bid to cut Jemperli royalties and affirming that AnaptysBio had not repudiated their Collaboration and Exclusive License Agreement. The ruling removes a key legal challenge to AnaptysBio’s royalty stream while clearing the way for a July 2026 trial on AnaptysBio’s allegations that Tesaro and GSK materially breached the collaboration, including...
NYSE:ADC
NYSE:ADCRetail REITs

A Look At Agree Realty (ADC) Valuation After Strong Q1 Results And Record Acquisition Activity

Agree Realty (ADC) has drawn fresh attention after reporting first quarter 2026 results with year over year growth in core FFO and AFFO per share, while also completing its largest acquisition volume since 2022. See our latest analysis for Agree Realty. Despite the recent flurry of capital raises and acquisitions, Agree Realty’s share price has been steady overall, with a 30 day share price return of 3.06% and a 90 day share price return of 5.56%. The 5 year total shareholder return of 34.45%...
ASX:IGO
ASX:IGOMetals and Mining

IGO (ASX:IGO) Is Down 24.2% After Cutting Greenbushes Guidance Is The Core Thesis Intact?

In April 2026, IGO Limited reported Q3 results and cut full-year production guidance at the Greenbushes lithium mine, citing systemic operational issues that are expected to take time to address. This shift in guidance highlights that the challenges at Greenbushes appear more structural than short term, raising questions about the mine’s operational resilience and reliability as a core asset. We’ll now examine how the Greenbushes guidance cut and persistent operational challenges shape IGO’s...
SASE:1180
SASE:1180Banks

Middle Eastern Dividend Stocks To Boost Your Portfolio

As geopolitical tensions and economic uncertainties continue to shape the Middle East, most Gulf equities have managed to nudge higher, reflecting a resilient market despite stalled diplomatic efforts in the region. In this environment, dividend stocks can offer investors a stable income stream and potential portfolio diversification, making them an attractive option for those seeking reliable returns amidst volatility.
NasdaqGS:MCHP
NasdaqGS:MCHPSemiconductor

Does Microchip (MCHP) Leaning Into Intel-Aligned AI Timing Refine Its Margin Recovery Story?

Earlier this month, Microchip Technology introduced its MD-990-0011-B plug-in timing modules, co-developed with Intel, to provide turnkey, high-precision synchronization for Intel Xeon 6–based data center servers and 5G vRAN infrastructure, alongside multiple embedded controller and security-focused product launches and a new authorized distribution agreement with Spirit Electronics. Together, these initiatives show Microchip pushing deeper into AI data center timing, secure edge control,...
TSXV:AFM
TSXV:AFMMetals and Mining

3 Dividend Fortresses With 5% Plus Yields And Surprisingly Low Earnings Multiples

Global markets are wrestling with shifting interest-rate expectations, inflation worries linked to energy prices, and renewed attention on sovereign debt. In that kind of backdrop, many investors are looking for reliability in their portfolio income rather than chasing the latest story. That is where the Dividend Fortresses screener comes in, focusing on companies with 5%+ dividend yields and an emphasis on resilience through different market conditions. In this article, you will see three of...
TSX:FCR.UN
TSX:FCR.UNRetail REITs

Assessing First Capital REIT (TSX:FCR.UN) Valuation After Strong Recent Total Returns

Recent performance context for First Capital Real Estate Investment Trust First Capital Real Estate Investment Trust (TSX:FCR.UN) has drawn fresh attention after a strong recent run, with the unit price rising about 14% over the past month and roughly 19% over the past 3 months. Over a longer horizon, the REIT’s total return is about 23% year to date and roughly 46% over the past year, while its 3 year and 5 year total returns stand near 72% and 65% respectively. See our latest analysis for...
NYSE:CCK
NYSE:CCKPackaging

Crown Holdings (CCK) Expands Into India With New Can Plant Is Its Global Strategy Evolving?

Crown Holdings has announced plans to build a new beverage can manufacturing facility in Northern India, expected to start operations in the second half of 2027 with capacity of about 2.20 billion cans a year to serve growing demand for aluminum packaging across alcoholic and non-alcoholic drinks. The project, backed by long-term customer commitments including United Breweries Limited and designed around advanced, sustainability-focused manufacturing standards, marks Crown’s entry into India...
NYSE:AU
NYSE:AUMetals and Mining

AngloGold Ashanti (NYSE:AU) Valuation Check As Capped Cash Tender Offers Signal Active Debt Management

AngloGold Ashanti (NYSE:AU) is in focus after AngloGold Ashanti Holdings plc reported early results from capped cash tender offers to buy back up to $650,000,000 of its outstanding 2028, 2030, and 2040 notes. See our latest analysis for AngloGold Ashanti. The tender offer update comes as AngloGold Ashanti’s share price sits at US$99.30, with a 1 month share price return of 11.36% and a year to date share price return of 16.00%. The 1 year total shareholder return of 162.17% and 5 year total...
NYSE:UTI
NYSE:UTIConsumer Services

A Look At Universal Technical Institute’s Valuation As Strong Multi Year Returns Meet A Higher P/E Multiple

Recent share performance and business snapshot Universal Technical Institute (UTI) has recently drawn investor attention after a period of mixed share performance, with declines over the past week and month alongside a positive move in the past 3 months and solid year to date gains. The company operates two segments: UTI and Concorde. It provides transportation, skilled trades, and healthcare education programs across the United States, and reports annual revenue of US$855.031 million and net...